1.Immunophenotype and bone marrow of chronic lymphocytic leukemia
International Journal of Laboratory Medicine 2016;37(7):898-899,903
Objective To study the characteristics of immunophenotype and bone marrow in chronic lymphocytic leukemia (CLL) in order to provide certain reference for its clinical diagnosis and treatment .Methods A total of 69 cases of CLL in our hos‐pital from January 2013 to January 2015 were selected .The immune 69 cases was analyzed by using the single parameter and multi‐parameter flow cytometry .The bone marrow and blood examinations were performed and the myeloproliferative degree was ana‐lyzed .Results Among 69 cases of CLL ,33 cases (47 .83% ) were LL/SL‐MC ,16 cases (23 .19% ) were CLL/PLL‐MC ,9 cases (13 .04% ) were TSL ,4 cases (5 .80% ) were ATLL ,4 cases (5 .80% ) were PLL and 3 cases (4 .34% ) were HCL .The majority of CLL cases were more than 50 years old .The myeloproliferative degree was hyperactive in 12 cases (17 .39% ) ,significantly active in 10 cases (14 .49% ) and active in 47 cases (68 .12% );the myeloid‐erythroid ratio was increased in 17 cases (24 .64% ) ,normal in 29 cases (42 .03% ) and reduced in 23 cases (33 .33% );the megakaryocyte count was increased in 3 cases (4 .35% ) ,normal in 30 cases (43 .48% ) and reduced in 36 cases (52 .17% ) .All 69 cases expressed CD19 and CD20 with the positive rate of 100% ;sec‐ondly expressed CD22 with the positive rate of 98 .55% ;the CD23 positive rate was 97 .10% ,the CD5 positive rate was 86 .96% ;all cases did not express CD10 .Conclusion The immunophenotype in 69 cases of CLL was mainly the mixed type with higher my‐eloproliferative degree ;the immunophenotype expressed CD19 and CD20 in all cases ,secondly expressed CD22 and CD23 ,and did not express CD10 .
2.Detection and analysis on blood serum infectious indicators in patients before receiving blood transfusion
International Journal of Laboratory Medicine 2016;37(8):1026-1027
Objective To detect and analysis on serum infectious indicators in patients before receiving blood transfusion .Meth‐ods 5 790 patients admitted to the hospital from June 2012 to April 2015 to be treated with blood transfusion were enrolled in the study and underwent detections of various infectious indicators ,including Hepatitis B surface antigen(HBsAg) ,anti hepatitis C vi‐rus antibody(anti‐HCV) ,anti human immunodeficiency virus antibody (anti‐HIV) and anti syphilis helicoid antibody (anti‐TP) . The positive rate of infectious indicators in 5 790 cases of blood transfusion before transfusion ,the positive rate of infectious indica‐tors in different departments and the positive rate of infectious indicators in patients of different gender were calculated .Results The positive rate of HBsAg was the highest ,which was 18 .2% .The positive rate of anti‐HIV was the lowest ,which was only 0 .26% .In obstetrics and gynecology department ,the positive rate of HBsAg and anti‐HIV were the highest ,and the positive rate of anti‐HCV and anti‐TP were basically the same in each department .The positive rate of HBsAg ,anti‐HCV ,anti‐HIV and anti‐TP in male blood recipients before transfusion were higher than that of female ,the difference was statistically significant(P<0 .05) . Conclusion It is very necessary to detect the serum infectious indicators in blood recipients before blood transfusion ,which can ef‐fectively block the spread of infectious diseases such as hepatitis ,AIDS ,syphilis and so on and protect blood recipients and medical workers .
3.Improvement of sleep and anxiety in patients of major depression with fluoxetine combined with small dose of olanzapine
Chinese Journal of Tissue Engineering Research 2005;9(8):254-256
BACKGROUND: Major depression is a subtype of depression. Application of thymoleptics alone has bad effect. It has shown from relevant studies abroad that application of fluoxetine combined with atypical antipsychotic drugs maybe an effective treating strategy.OBJECTIVE: To observe the curative effects of fluoxetine combined with olanzapine and the time of its taking effect.DESIGN: Comparative study of open clinical test with completely random sampling for the first visit outpatients SETTING: A psychological consulting clinic in a hospital of a Military Medical College of Chinese PLA.PARTICIPANTS: Totally 140 patients visiting psychological counseling outpatient clinic in the hospital were collected from January 2004 to August 2004. Inclusion criteria: According to the diagnostic criterion of depression of CCMD-3, patients with total scores of 17 items in Hamilton depression rating scale≥28and age ≥18 years old .EXclusion criteria;①slight to middle edgree of depression(Hamt≤27);②secondary depression;③convalesscent period of schizophrenia and other affective disorder caused by psychosis;④severe of unstable body diseases ,including diseases of liver,kidney,cardiae vessel,respiration,gastro-intestine,endocrine,nervous system,innune system or hematological system,cet.⑤drug or alcohol addict;⑥women in pregnancy and lactation. Totally 110 patients accorded with the inclusive criteria. Among them, there were 40 males and 70 females with the course of disease for 4 months to 5 years, aged 18 to 63 with the average (37 ± 12) years old. They all took part in the trial voluntarily. According to the date of admittance, they were divided into odd-numbered date alprazolam group in which there were 55 patients with 21 males and 34 females and double date olanzapine group in which there were 55 patients with 19 males and 36 females.METHODS: The patients were divided into 2 groups according to the date of admittance. Odd-numbered date group was alprazolam group. 0.4 mg alprazolam was given every noon and before sleep and 20 mg fluoxetine was given at a draught after breakfast every day. Even-numbered date group was olanzapine group. 2.5 mg olanzapine was given before sleep every day and 20mg fluoxetine was given at a draught after breakfast every day. The course of treatment was 6 weeks. HAMD and HAMA scores of taken were evaluated respectively before and at the end of 1st, 2nd, 4th and 6th week. Reducing score rate was used to decide effective time. Lost rate was presented as percentage. And improvement of sleep factor and somatization factor in HAMD were observed before therapy and at every observing time period after therapy.MAIN OUTCOME MEASURES: Terminus index: Comparison of HAMD,HAMA score in the two groups before therapy and at the 1st, 2nd, 4th and 6th weekend after therapy. Scores of sleep factor and anxiety somatization factor of HAMD at every observing time period in the two groups. Substitution index: lost rate in the two groups. Reducing score rate at every observing time period in the two groups.RESULTS: Lost rate in olanzapine group was significantly lower than that in alprazolam group ( P < 0.05) and the effect was taken at 1 week after therapy(excellence rate 67% ) . But, scores of HAMD and HAMA at every observing time period in olanzapine group were significant lower than those in alprazolam group( P < 0.01) and sleep factor and somatization factor at every observing time period improved more significantly than those of alprazolam group( P < 0. 01).CONCLUSION: Small amount of olanzapine combined with fluoxetine used to treat major depression of the patients can improve sleep and anxiety body symptoms rapidly and then elevate their living quality significantly.
4. Influence of C-type natriuretic peptide on expression of natriuretic peptide B receptor suppressed by advanced glycation end products and on post-receptor signal regulation
Academic Journal of Second Military Medical University 2010;28(7):758-760
Objective: To investigate the influence of C-type natriuretic peptide (CNP) on the expression of natriuretic peptide B receptor(NPR-B) and its cGMP signal induced by advanced glycation end products(AGEs) in human mesangial cells(HMC). Methods: HMCs were cultured in vitro. The expression of NPR-B, intracellular concentration of cGMP and level of NF-κB p65 in HMC were measured by immunofluorescent staining, enzyme linked immunosorbent assay(ELISA) and flow cytometry, respectively. Results: CNP significantly upregulated the immunofluorescent intensity of NPR-B and the concentration of cGMP inhibited by AGEs(P<0.001);CNP also inhibited the fluorescent intensity of NF-κB p65 stimulated by AGEs. Conclusion: CNP can regulate the expression of NPR-B/cGMP and activity of NF-κB induced by AGEs through a NPR-B/cGMP dependent manner.
5. Thyroperoxidase expression in fine needle aspirated thyroid tumor cells and it clinical relevance
Academic Journal of Second Military Medical University 2010;27(12):1315-1319
Objective:To observe thyroperoxidase (TPO) expression in fine needle aspirated thyroid tumor cells and to assess the value TPO immunostaining in differential diagnosis of benign and malignant thyroid tumors. Methods: Fine needle aspiration (FNA) samples, and frozen tissue sections of 71 surgically resected thyroid tumor specimens were immunostained by with hTPO MoAb47. The staining results were considered positive if 80% or more thyroid cells were positively stained. Results: TPO expression levels in FNA samples and frozen tissue sections of malignant tumors were lower than those of benign tumors (P<0.01), and there was no difference in the results of FNA and frozen tissue sections. We also found that the TPO staining intensity of malignant tumors was markedly lower than that of benign tumors, with significant differences found between the mean densities, relative optic densities, and the intensities of staining color (all P<0.05), but with no significant difference found between the results of FNA samples and frozen tissue sections. TPO staining was positive in 20 of the 22 smears of the benign cystoma and in none of the 4 smears of malignant cystoid lesion (P<0.05). Taking the results of H-E staining as the control, the sensitivity of FNA samples was 95.74% and the specificity was 91.67%; of frozen tissue section were 100% and 66.47%; and of the cystoid lesions smears were 97.44% and 88.46%, respectively. Conclusion: TPO expression level is obviously higher in benign thyroid tumors than those in the malignant ones. FNA samples can be used for TPO immunocytochemistry staining as an adjuvant tool for distinguishing benign and malignant tumors.
6.The randomized placebo-controlled trial on fluoxetine combined with olanzapine in treating major depression
Journal of Third Military Medical University 2003;0(10):-
Objective To evaluate the efficacy and effective time of low dosage of olanzapine combined with fluoxetine in treatment of major depression. Methods A total of 53 patients who suffered from major depression diagnosed according to CCMD-3 and the score of Hamilton rating scale for depression (HAMD) over 28, were randomly divided into 2 groups: alprazolam group (0.4 mg alprazolam, 2/d and 20 mg fluoxetine, 1/d), olanzapine group (2.5 mg olanzapine, 1/d, and 20 mg fluoxetine, 1/d). The treatment period lasted six weeks and the subjects were evaluated by using HAMD and HAMA at week 1, 2, 4, 6. The effective time was estimated by decreasing rate of the scale of HAMD and the amelioration of sleep disturbance and anxiety/somatization in HAMD were observed before and during the treatment. Results The therapeutic effects in olanzapine group at week 1 were observed with the apparent rate of 67%. The scores of HAMD and HAMA in olanzapine group were obviously lower than those in alprazolam group at each time point. The sleep disturbance and anxiety/somatization of the patients in olanzapine group improved significantly as compared with those in alprazolam group. Conclusion Fluoxetine combined with olanzapine is a fast and effective method to treat major depression.
7.Research progress of non-receptor tyrosine kinase signal transducer and activator of transcription as a new target in colon cancer
Cancer Research and Clinic 2016;28(2):129-132
Malignant colon cells require angiogenesis and optimal tumor microenvironment for proliferation, invasion and metastasis. The non-receptor tyrosine kinase signal transducer and activator of transcription (JAK-STAT) pathway are involved in multiple processes, including chronic inflammation-associated tumorigenesis, cancer proliferation, tumor angiogenesis, immune evasion and facilitating tumor metastasis, making JAK-STAT a new target in molecular target therapy. In this review, advances on JAK-STAT pathway as a new target in colon tumorigenesis are updated, and a preliminary estimation of JAK-STAT in prognosis and target therapy will be mentioned to show a potential future of JAK-STAT in colon cancer.
8.Efficacy of biomimicking chitosan scaffolds in bridging large nerve defect
Orthopedic Journal of China 2006;0(05):-
[Objective] To develop biomimicking chitosan scaffolds with longitudinally oriented micro-channels,and investigate their efficacy in bridging 15 mm sciatic nerve gap in rats.[Methods]Chitosan scaffolds with longitudinally oriented micro-channels were fabricated using unidirectional freezing-dry methods.The chitosan scaffolds were used to bridge 15 mm nerve defect in rats,and their efficacy in bridging nerve gap was evaluated by morphometric analysis,retrograde labeling,electrophysiological studies and behavioral analysis.[Results]The chitosan scaffolds developed in the present study showed longitudinally oriented micro-channels,which resembled the dimensions of basal lamina channels in normal nerves.Implantation of chitosan scaffold achieved axonal regeneration and functional recovery similar to autograft implantation in vivo.[Conclusion]The chitosan scaffolds have inner microstructures which resemble the basal lamina channels in normal nerves.The chitosan scaffold may be used as an alternative to autograft in bridging nerve gaps.
9.Expression of CA199,CA724 and CEA in gastric cancer and clinical significance.
Xueping ZENG ; Wei QU ;
Chinese Journal of Practical Internal Medicine 2006;0(S2):-
Objective To explore the express levels of CA199,CA724 and CEA in different gastric mucosa pathological situation.Methods The experimental group included 82 cases including 15 of chronic atrophic gastritis,15 of intesti- nal metapiasia,15 of dysplasia of the gastric mucosa,19 of gastric ulcer,18 of gastric cancer;15 of the chronic Super- ficial gastritis (CSG) were set as control group.To test express levels of CA199,CA724 and CEA in these cases by the immunohistochemistry technology.Results The positive rate of CA199,CA724 and CEA in gastric cancer was sig- nificantly higher than that in precancerous lesion groups and precancerous state groups (P0.05),but there was a graduate increasing of the positive rate of CA199,CA724 expression in chronic atrophic gastritis,intestinal metaplasia and dysplasia of the gastric mucosa. Conclusion That different expression of CA199,CA724 and CEA in gastric cancer development situation may be help- ful for the early diagnose of gastric cancer.
10.Clinical study ofWenyang-Gushen-Huayu decoction on treating diabetic nephropathy
International Journal of Traditional Chinese Medicine 2016;38(9):787-789
Objective To assess the clinical effectiveness ofWenyang-Gushen-Huayu decoction on treating diabetic nephropathy (DN).Methods One hundred and twenty DN patients in Hospital of Penglai Chinese Medicine were included and randomly divided into treatment group and observation group. Both groups were given conventional treatment, and the treatment group was added withWenyang-Gushen-Huayu decoction. One course of treatment lasted four weeks in both groups and each group was observed for 2 courses. The clinical symptoms, vital signs, urinary albumin excretion rate (UAER), and 24 h urinary proteinwere observed. Results The treatment group showed significantly higher effective rate (93.34%vs.73.33%) than that in the control groupa(χ2=8.640,P=0.003). TheWenyang-Gushen-Huayu decoction significantly improved the symptoms of waist chills (2.47 ± 1.11vs.2.92 ± 1.36,t=1.986), edema of face and feet (1.81 ± 0.96vs.2.14 ± 1.01,t=5.165), fatigue of the gods (2.83 ± 1.12vs.3.51 ± 1.18,t=3.237), UAER (326.4 ± 98.7μg/minvs. 421.5 ± 185.6μg/min;t=3.504) and UP (0.7 ± 0.33 g/24hvs. 1.0 ± 0.37 g/24h;t=1.845).ConclusionsTheWenyang-Gushen-Huayu decoction could improve the symptoms and reduce UAER of DN patients.